Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis

Table 1 Levels of serum triglyceride, cytokines and APACHE II score

	PF	AFE	AF7
Serum triglyceride (mmol/L)	13.1 ± 8.1	4.5 ± 2.3	2.02 ± 0.83
APACHE II score	18.4 ± 4.4	7.38 ± 2.5	5.8 ± 1.5
TNFα (u/mL)	43.1 ± 12.7	26.3 ± 7.5	17.7 ± 5.6
IL-10 (pg/mL)	72.1 ± 20.0	179.6 ± 23.9	31.2 ± 11.5

Table 2 Surgical intervention

	SAP	FSAP
Number of cases	5	7
Time of first operating (days)	55.8 ± 42.6	12.2 ± 6.6
Surgical procedures	Debridement and gastro-or jejuno-pancreatic anastomosis for pseudocyst	Debridement with drainage and nutritional jejunostomy
Number of operation	1.33 ± 0.5	3.5 ± 1.2

Table 3 Prognosis of SAP and FSAP

	SAP group	FSAP group
Number of cases	22	9
Rate of adsorption of pseudocyst	77.3% (17/22)	11.1% (1/9)
Time interval for absorptionof pseudocyst	135.1 ± 137.5	96
Non-operation cure rate	100% (22/22)	11.1% (1/9)
Hospital stay (days)	54.2 ± 35.9	99.1 ± 49.5
Survival rate	100% (22/22)	66.7% (6/9)